Hijmering-Kappelle LBM, Hiltermann TJN, Bensch F. Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer During the COVID-19 Pandemic. Clin Lung Cancer 2021 Dec 24. pii: S1525-7304(21)00305.
PMID: 35034861